234 related articles for article (PubMed ID: 25331796)
41. uPAR expression under hypoxic conditions depends on iNOS modulated ERK phosphorylation in the MDA-MB-231 breast carcinoma cell line.
Yoon SY; Lee YJ; Seo JH; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
Cell Res; 2006 Jan; 16(1):75-81. PubMed ID: 16467878
[TBL] [Abstract][Full Text] [Related]
42. GD₃ synthase expression enhances proliferation and tumor growth of MDA-MB-231 breast cancer cells through c-Met activation.
Cazet A; Lefebvre J; Adriaenssens E; Julien S; Bobowski M; Grigoriadis A; Tutt A; Tulasne D; Le Bourhis X; Delannoy P
Mol Cancer Res; 2010 Nov; 8(11):1526-35. PubMed ID: 20889649
[TBL] [Abstract][Full Text] [Related]
43. GSK-3β suppresses the proliferation of rat hepatic oval cells through modulating Wnt/β-catenin signaling pathway.
Ji XK; Xie YK; Zhong JQ; Xu QG; Zeng QQ; Wang Y; Zhang QY; Shan YF
Acta Pharmacol Sin; 2015 Mar; 36(3):334-42. PubMed ID: 25661318
[TBL] [Abstract][Full Text] [Related]
44. Upregulated IQUB promotes cell proliferation and migration via activating Akt/GSK3β/β-catenin signaling pathway in breast cancer.
Li K; Ma YB; Zhang Z; Tian YH; Xu XL; He YQ; Xu L; Gao Y; Pan WT; Song WJ; He X; Wei L
Cancer Med; 2018 Aug; 7(8):3875-3888. PubMed ID: 29968965
[TBL] [Abstract][Full Text] [Related]
45. The intrinsically kinase-inactive EPHB6 receptor predisposes cancer cells to DR5-induced apoptosis by promoting mitochondrial fragmentation.
El Zawily AM; Toosi BM; Freywald T; Indukuri VV; Vizeacoumar FJ; Leary SC; Freywald A
Oncotarget; 2016 Nov; 7(47):77865-77877. PubMed ID: 27788485
[TBL] [Abstract][Full Text] [Related]
46. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
[TBL] [Abstract][Full Text] [Related]
47. Coupling G2/M arrest to the Wnt/β-catenin pathway restrains pancreatic adenocarcinoma.
Sarkar S; Mandal C; Sangwan R; Mandal C
Endocr Relat Cancer; 2014 Feb; 21(1):113-25. PubMed ID: 24402132
[TBL] [Abstract][Full Text] [Related]
48. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ
Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149
[TBL] [Abstract][Full Text] [Related]
49. Involvement of PPAR gamma and E-cadherin/beta-catenin pathway in the antiproliferative effect of conjugated linoleic acid in MCF-7 cells.
Bocca C; Bozzo F; Francica S; Colombatto S; Miglietta A
Int J Cancer; 2007 Jul; 121(2):248-56. PubMed ID: 17354222
[TBL] [Abstract][Full Text] [Related]
50. MAPK/ERK and Wnt/β-Catenin pathways are synergistically involved in proliferation of Sca-1 positive hepatic progenitor cells.
Jin C; Samuelson L; Cui CB; Sun Y; Gerber DA
Biochem Biophys Res Commun; 2011 Jun; 409(4):803-7. PubMed ID: 21624348
[TBL] [Abstract][Full Text] [Related]
51. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
[TBL] [Abstract][Full Text] [Related]
52. Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling.
van de Wetering M; Barker N; Harkes IC; van der Heyden M; Dijk NJ; Hollestelle A; Klijn JG; Clevers H; Schutte M
Cancer Res; 2001 Jan; 61(1):278-84. PubMed ID: 11196175
[TBL] [Abstract][Full Text] [Related]
53. E-cadherin, as a negative regulator of invasive behavior of human trophoblast cells, is down-regulated by cyclosporin A via epidermal growth factor/extracellular signal-regulated protein kinase signaling pathway.
Zhao HB; Wang C; Li RX; Tang CL; Li MQ; Du MR; Hou XF; Li DJ
Biol Reprod; 2010 Sep; 83(3):370-6. PubMed ID: 20427760
[TBL] [Abstract][Full Text] [Related]
54. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
[TBL] [Abstract][Full Text] [Related]
55. PCDH10 inhibits cell proliferation of multiple myeloma via the negative regulation of the Wnt/β-catenin/BCL-9 signaling pathway.
Xu Y; Yang Z; Yuan H; Li Z; Li Y; Liu Q; Chen J
Oncol Rep; 2015 Aug; 34(2):747-54. PubMed ID: 26081897
[TBL] [Abstract][Full Text] [Related]
56. Transactivation of lifeguard (LFG) by Akt-/LEF-1 pathway in MCF-7 and MDA-MB 231 human breast cancer cells.
Bucan V; Adili MY; Choi CY; Eddy MT; Vogt PM; Reimers K
Apoptosis; 2010 Jul; 15(7):814-21. PubMed ID: 20336373
[TBL] [Abstract][Full Text] [Related]
57. Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation.
Yun MS; Kim SE; Jeon SH; Lee JS; Choi KY
J Cell Sci; 2005 Jan; 118(Pt 2):313-22. PubMed ID: 15615777
[TBL] [Abstract][Full Text] [Related]
58. Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression.
Usongo M; Li X; Farookhi R
Dev Dyn; 2013 Mar; 242(3):291-300. PubMed ID: 23239518
[TBL] [Abstract][Full Text] [Related]
59. P2 purinergic receptors signal to glycogen synthase kinase-3beta in astrocytes.
Neary JT; Kang Y
J Neurosci Res; 2006 Aug; 84(3):515-24. PubMed ID: 16810687
[TBL] [Abstract][Full Text] [Related]
60. EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.
Toosi BM; El Zawily A; Truitt L; Shannon M; Allonby O; Babu M; DeCoteau J; Mousseau D; Ali M; Freywald T; Gall A; Vizeacoumar FS; Kirzinger MW; Geyer CR; Anderson DH; Kim T; Welm AL; Siegel P; Vizeacoumar FJ; Kusalik A; Freywald A
Oncogene; 2018 Jul; 37(30):4073-4093. PubMed ID: 29700392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]